A multivariate analysis of clinical and morphological prognostic factors in squamous cell carcinoma of the vulva

被引:16
作者
SmyczekGargya, B [1 ]
Volz, B [1 ]
Geppert, M [1 ]
Dietl, J [1 ]
机构
[1] UNIV WURZBURG,DEPT OBSTET & GYNECOL,WURZBURG,GERMANY
关键词
squamous cell carcinoma of the vulva; multivariate analysis; univariate analysis;
D O I
10.1159/000291869
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Clinical and histological data of 168 patients with squamous cell carcinoma of the vulva were analyzed with respect to survival. 151 patients underwent surgery, 12 patients were treated with primary radiation and in 5 patients no treatment was performed. Follow-up lasted from at least 2 up to 22 years' posttreatment. In univariate analysis, the following factors were highly significant: presurgery lymph node status, tumor infiltration beyond the vulva, tumor grading, histological inguinal lymph node status, pre- and postsurgery tumor stage, depth of invasion and tumor diameter. In the multivariate analysis (Cox regression), the most powerful factors were shown to be histological inguinal lymph node status, tumor diameter and tumor grading. The multivariate logistic regression analysis worked out as main prognostic factors for metastases of inguinal lymph nodes: presurgery inguinal lymph node status, tumor size, depth of invasion and tumor grading. Based on these results, tumor biology seems to be the decisive factor concerning recurrence and survival. Therefore, we suggest a more conservative treatment of vulvar carcinoma. Patients with confined carcinoma to the vulva, with a tumor diameter up to 3 cm and without clinical suspected lymph nodes, should be treated by wide excision/partial vulvectomy with ipsilateral lymphadenectomy.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 38 条
[1]  
ADRION RO, 1989, ARCH GYNECOL OBSTET, V245, P529
[2]  
ANDERSON JA, 1981, OBSTET GYNECOL, V58, P364
[3]   PREDICTIVE FACTORS WITH REFERENCE TO LOW-RISK OF METASTASES IN SQUAMOUS-CELL CARCINOMA IN THE VULVAR REGION [J].
ANDREASSON, B ;
NYBOE, J .
GYNECOLOGIC ONCOLOGY, 1985, 21 (02) :196-206
[4]   VALUE OF PROGNOSTIC PARAMETERS IN SQUAMOUS-CELL CARCINOMA OF THE VULVA [J].
ANDREASSON, B ;
NYBOE, J .
GYNECOLOGIC ONCOLOGY, 1985, 22 (03) :341-351
[5]   REGIONAL LYMPH-NODE RECURRENCE FOLLOWING LOCAL EXCISION FOR MICROINVASIVE VULVAR CARCINOMA [J].
ATAMDEDE, F ;
HOOGERLAND, D .
GYNECOLOGIC ONCOLOGY, 1989, 34 (01) :125-128
[6]  
Bender H G, 1989, Arch Gynecol Obstet, V245, P513, DOI 10.1007/BF02417401
[7]   CISPLATIN (P), BLEOMYCIN (B), AND METHOTREXATE (M) PREOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED VULVAR CARCINOMA [J].
BENEDETTIPANICI, P ;
GREGGI, S ;
SCAMBIA, G ;
SALERNO, G ;
MANCUSO, S .
GYNECOLOGIC ONCOLOGY, 1993, 50 (01) :49-53
[8]  
BORONOW R C, 1973, Gynecologic Oncology, V1, P233, DOI 10.1016/0090-8258(73)90015-2
[9]   COMBINED THERAPY AS AN ALTERNATIVE TO EXENTERATION FOR LOCALLY ADVANCED VULVO-VAGINAL CANCER .2. RESULTS, COMPLICATIONS, AND DOSIMETRIC AND SURGICAL CONSIDERATIONS [J].
BORONOW, RC ;
HICKMAN, BT ;
REAGAN, MT ;
SMITH, RA ;
STEADHAM, RE .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (02) :171-181
[10]  
BORONOW RC, 1982, CANCER, V49, P1085, DOI 10.1002/1097-0142(19820315)49:6<1085::AID-CNCR2820490605>3.0.CO